Using the comprehensive survival analysis platforms Kaplan-Meier plotter, Oncomine, and PrognoScan, we have demonstrated the oncogenic role of STAT3 in ovarian, lung, blood, and brain cancer, however, which is not clear in breast cancer. This evidence concerns the gene STAT3 and breast carcinoma.